RFS
NVAX icon

Rockefeller Financial Services’s Novavax NVAX Stock Holding History

Rockefeller Financial Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-820
Closed -$183K – 521
2015
Q2 		$183K Buy
+820
New +$144K ﹤0.01% 324

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rockefeller Financial Services's NVAX Position: Q3 2015 in Review

Rockefeller Financial Services sold out of Novavax (NVAX) in Q3 2015, closing a stake of 820 shares — an estimated $183K sold.

Rockefeller Financial Services first reported a position in NVAX in Q2 2015 and held it in 1 quarter. The position peaked at $183K in Q2 2015. 190 funds tracked by Wall St. Rank hold NVAX as of Q3 2015.

  • Rockefeller Financial Services reported no remaining Novavax position as of Q3 2015 after selling out during the quarter.
  • Rockefeller Financial Services sold 820 Novavax shares in Q3 2015, an estimated $183K.
  • Rockefeller Financial Services first reported a position in Novavax in Q2 2015 and held it in 1 quarter.
  • Rockefeller Financial Services's Novavax position peaked at $183K in Q2 2015.
  • 190 funds tracked by Wall St. Rank held Novavax as of Q3 2015.

Based on Rockefeller Financial Services's 13F filing for Q3 2015, filed 23 Oct 2015.